Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
J Neurochem
    March 2024
  1. NETZAHUALCOYOTZI C, Santillan-Cigales JJ, Adalid-Peralta LV, Velasco I, et al
    Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases.
    J Neurochem. 2024 Mar 29. doi: 10.1111/jnc.16106.
    >> Share

  2. PLACIDO E, Koss DJ, Outeiro TF, Brocardo PS, et al
    Altered hippocampal doublecortin expression in Parkinson's disease.
    J Neurochem. 2024 Mar 14. doi: 10.1111/jnc.16101.
    >> Share

  3. KALINICHENKO LS, Kohl Z, Muhle C, Hassan Z, et al
    Sex-specific pleiotropic changes in emotional behavior and alcohol consumption in human alpha-synuclein A53T transgenic mice during early adulthood.
    J Neurochem. 2024;168:269-287.
    >> Share

    January 2024
  4. CARMONA A, Carboni E, Gomes LC, Roudeau S, et al
    Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis.
    J Neurochem. 2024 Jan 5. doi: 10.1111/jnc.16040.
    >> Share

    December 2023
  5. ZHANG F, Yang D, Li J, Du C, et al
    Synaptotagmin-11 regulates immune functions of microglia in vivo.
    J Neurochem. 2023;167:680-695.
    >> Share

  6. RENTSCH P, Egan T, Kuriakose A, Stayte S, et al
    The ratio of M1 to M2 microglia in the striatum determines the severity of L-Dopa-induced dyskinesias.
    J Neurochem. 2023;167:633-647.
    >> Share

    November 2023
  7. BILLINGS JL, Hilton JBW, Liddell JR, Hare DJ, et al
    Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseases.
    J Neurochem. 2023;167:337-346.
    >> Share

  8. SONG DY, Yuan L, Cui N, Feng C, et al
    alpha-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression.
    J Neurochem. 2023;167:461-484.
    >> Share

    September 2023
  9. WANG J, Joseph S, Vingill S, Dere E, et al
    Loss of the parkinsonism-associated protein FBXO7 in glutamatergic forebrain neurons in mice leads to abnormal motor behavior and synaptic defects.
    J Neurochem. 2023 Sep 27. doi: 10.1111/jnc.15962.
    >> Share

  10. MUHAMMAD B, Li H, Gu Y, Xue S, et al
    IL-1beta/IL-1R1 signaling is involved in the propagation of alpha-synuclein pathology of the gastrointestinal tract to the brain.
    J Neurochem. 2023;166:830-846.
    >> Share

  11. CHENG JY, Deng YT, Yu JT
    The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study.
    J Neurochem. 2023;166:972-981.
    >> Share

    July 2023
  12. WARTH PEREZ ARIAS CC, Silbern I, Caldi Gomes L, Wartmann H, et al
    Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease.
    J Neurochem. 2023 Jul 28. doi: 10.1111/jnc.15924.
    >> Share

    June 2023
  13. GASPAROTTO J, Somensi N, Girardi CS, Bittencourt RR, et al
    Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease.
    J Neurochem. 2023 Jun 28. doi: 10.1111/jnc.15890.
    >> Share

  14. HE H, Zhang Q, Liao J, Lei J, et al
    METTL14 is decreased and regulates m(6) A modification of alpha-synuclein in Parkinson's disease.
    J Neurochem. 2023 Jun 13. doi: 10.1111/jnc.15882.
    >> Share

  15. BARINGER SL, Simpson IA, Connor JR
    Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation.
    J Neurochem. 2023;165:625-642.
    >> Share

    April 2023
  16. MASUKAWA D, Kitamura S, Tajika R, Uchimura H, et al
    Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L-3,4-dihydroxyphenylalanine in the dorsal striatum.
    J Neurochem. 2023;165:177-195.
    >> Share

  17. BRONTESI L, Imberdis T, Ramalingam N, Dettmer U, et al
    The effects of KTKEGV repeat motif and intervening ATVA sequence on alpha-synuclein solubility and assembly.
    J Neurochem. 2023;165:246-258.
    >> Share

    February 2023
  18. CHEN YH, Kuo YY, You YQ, Lin YT, et al
    Endonuclease VIII-like 1 deficiency potentiates nigrostriatal dopaminergic neuron degeneration in a male mouse model of Parkinson's disease.
    J Neurochem. 2023 Feb 24. doi: 10.1111/jnc.15794.
    >> Share

  19. TENG X, Mao S, Wu H, Shao Q, et al
    The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
    J Neurochem. 2023 Feb 13. doi: 10.1111/jnc.15780.
    >> Share

    January 2023
  20. DE GUILHEM DE LATAILLADE A, Caillaud M, Oullier T, Naveilhan P, et al
    LRRK2 expression in normal and pathologic human gut and in rodent enteric neural cell lines.
    J Neurochem. 2023;164:193-209.
    >> Share

    November 2022
  21. PALDOR I, Madrer N, Vaknine Treidel S, Shulman D, et al
    Cerebrospinal fluid and blood profiles of transfer RNA fragments show age, sex and Parkinson's disease-related changes.
    J Neurochem. 2022 Nov 10. doi: 10.1111/jnc.15723.
    >> Share

    October 2022
  22. SANTORO M, Fadda P, Klephan KJ, Hull C, et al
    Neurochemical, histological and behavioral profiling of the acute, sub-acute and chronic MPTP mouse model of Parkinson's disease.
    J Neurochem. 2022 Oct 3. doi: 10.1111/jnc.15699.
    >> Share

    September 2022
  23. VAZ M, Martins TS, Henriques AG
    Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: methodologies applied from cells to biofluids.
    J Neurochem. 2022 Sep 26. doi: 10.1111/jnc.15697.
    >> Share

    April 2022
  24. SKITEVA O, Yao N, Sitzia G, Chergui K, et al
    LRRK2-G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons.
    J Neurochem. 2022;161:158-172.
    >> Share

    March 2022
  25. REN J, Pan C, Wang Y, Xue C, et al
    Plasma alpha-synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson's Disease.
    J Neurochem. 2022 Mar 2. doi: 10.1111/jnc.15601.
    >> Share

  26. XUE J, Li G, Ji X, Liu ZH, et al
    Drosophila ZIP13 over-expression or transferrin1 RNAi influences the muscle degeneration of Pink1 RNAi by elevating iron levels in mitochondria.
    J Neurochem. 2022;160:540-555.
    >> Share

    February 2022
  27. LO PS, Rymar VV, Kennedy TE, Sadikot AF, et al
    The Netrin-1 Receptor DCC Promotes the Survival of a Subpopulation of Midbrain Dopaminergic Neurons: Relevance for Ageing and Parkinson's Disease.
    J Neurochem. 2022 Feb 4. doi: 10.1111/jnc.15579.
    >> Share

    December 2021
  28. NICASTRO N, Nencha U, Burkhard PR, Garibotto V, et al
    Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.
    J Neurochem. 2021 Dec 22. doi: 10.1111/jnc.15561.
    >> Share

    November 2021
  29. GUO YJ, Ayton S, Lei P
    Iron reduces the propagation of pathological alpha-synuclein: An Editorial Highlight for "Brain iron enrichment attenuates alpha-synuclein spreading after injection of preformed fibrils" on page 554.
    J Neurochem. 2021;159:414-416.
    >> Share

    October 2021
  30. LEE CY, Menozzi E, Chau KY, Schapira AHV, et al
    Glucocerebrosidase 1 and leucine-rich repeat kinase 2 in Parkinson disease and interplay between the two genes.
    J Neurochem. 2021 Oct 7. doi: 10.1111/jnc.15524.
    >> Share

    September 2021
  31. BIDESI N, Andersen IV, Windhorst AD, Shalgunov V, et al
    The Role of Neuroimaging in Parkinson's Disease.
    J Neurochem. 2021 Sep 17. doi: 10.1111/jnc.15516.
    >> Share

    July 2021
  32. GOLDSTEIN DS, Sullivan P, Holmes C, Lamotte G, et al
    Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
    J Neurochem. 2021;158:554-568.
    >> Share

    June 2021
  33. MASATO A, Bubacco L, Greggio E
    Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease: An Editorial Highlight for "Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metaboli
    J Neurochem. 2021 Jun 28. doi: 10.1111/jnc.15442.
    >> Share

  34. KHAIRNAR A, Ruda-Kucerova J, Arab A, Hadjistyllis C, et al
    Diffusion kurtosis imaging detects the time-dependent progress of pathological changes in the oral rotenone mouse model of Parkinson's disease.
    J Neurochem. 2021 Jun 9. doi: 10.1111/jnc.15449.
    >> Share

    May 2021
  35. LASHUEL HA
    Alpha-Synuclein oligomerization and aggregation: All models are useful but only if we know what they model: This is the reply to a comment "Alpha-synuclein oligomerization and aggregation: A model will always be a model" on the original article "Monit
    J Neurochem. 2021;157:891-898.
    >> Share

    April 2021
  36. PISCHEDDA F, Piccoli G
    LRRK2 at the pre-synaptic site: A 16-years perspective.
    J Neurochem. 2021;157:297-311.
    >> Share

    January 2021
  37. LV Q, Zhong Z, Hu B, Yan S, et al
    MicroRNA-3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson's disease.
    J Neurochem. 2021 Jan 15. doi: 10.1111/jnc.15299.
    >> Share

    December 2020
  38. PINNELL JR, Cui M, Tieu K
    Exosomes in Parkinson Disease.
    J Neurochem. 2020 Dec 29. doi: 10.1111/jnc.15288.
    >> Share

  39. ZARATE SM, Pandey G, Chilukuri S, Garcia JA, et al
    Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-beta-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons.
    J Neurochem. 2020 Dec 23. doi: 10.1111/jnc.15282.
    >> Share

  40. HADI F, Akrami H, Totonchi M, Farhadi A, et al
    alpha-Synuclein Abnormalities Trigger Focal Tau Pathology, Spreading to Various Brain Areas in Parkinson's Disease.
    J Neurochem. 2020 Dec 2. doi: 10.1111/jnc.15257.
    >> Share

    September 2020
  41. TUO QZ, Lei P
    Iron promotes the clearance of alpha-synuclein: An Editorial for 'H63D variant of the homeostatic iron regulator (HFE) gene alters alpha-synuclein expression, aggregation, and toxicity" on page 177.
    J Neurochem. 2020;155:117-119.
    >> Share

    August 2020
  42. TRINH D, Israwi AR, Arathoon LR, Gleave JA, et al
    The multi-faceted role of mitochondria in the pathology of Parkinson's disease.
    J Neurochem. 2020 Aug 16. doi: 10.1111/jnc.15154.
    >> Share

    July 2020
  43. TOFFOLI M, Smith L, Schapira AHV
    The biochemical basis of interactions between Glucocerebrosidase and alpha-synuclein in GBA1 mutation carriers.
    J Neurochem. 2020;154:11-24.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016